— Know what they know.
Not Investment Advice

RPTX Earnings

Repare Therapeutics Inc.
1W: +19.8% 1M: +22.1% 3M: +45.2% 1Y: +101.5% 3Y: -82.1% 5Y: -92.2%
$2.65
Last traded 2025-12-31 — delisted
NASDAQ · Healthcare · Biotechnology · $114.2M mcap · 35M float · 3.39% daily turnover · Short 35% of daily vol
Last Earnings 2026-03-02
EPS
$-0.67
▼ Miss -131.0%
Revenue
$2M
Est (actual pending)
Next Earnings Qtr ending 2026-12-30 · date TBD
EPS Estimate
$-0.32
Range: $-0.32 - $-0.32
Revenue Estimate
$2M
1 analysts

Estimate vs Actual

Earnings Surprise History

11/20
EPS Beats
9/20
Revenue Beats
55%
EPS Beat Rate
45%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms